GlycoMark
Use
GlycoMark is intended for use with managing glycemic control in diabetic patients. It provides a measure of glycemic control over a short-to-medium period. A low GlycoMark result indicates the occurrence of high glucose peaks, which are associated with increased risks of complications in diabetes management.
Special Instructions
Not provided.
Limitations
1,5-Anhydroglucitol (1,5-AG) levels can be influenced by certain physiological and pharmacological conditions. Medications and clinical states that impact renal glucose excretion can lead to variations in 1,5-AG levels, potentially affecting test accuracy. Proper management of these variables is critical for reliable results, and re-evaluation is recommended if initial results suggest unaccounted influences.
New York Approved
Methodology
Other
Biomarkers
1-5-Anhydroglucitol (1,5-AG)
Analyte
LOINC Codes
- 53835-5 - 1,5-Anhydroglucitol SerPl-mCnc
- 53835-5 - 1,5-Anhydroglucitol SerPl-mCnc
Result Turnaround Time
5-12 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.75 mL
Container
Plastic vial
Collection Instructions
Draw blood in a plain red-top tube(s), serum gel tube is acceptable. Spin down and send 1 mL of serum ambient in a plastic vial.
Causes for Rejection
Hemolysis, Lipemia, Icterus, Other
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 14 days |